Literature DB >> 22975410

Role of the alternative and classical complement activation pathway in complement mediated killing against Streptococcus pneumoniae colony opacity variants during acute pneumococcal otitis media in mice.

Qian Li1, Yong Xing Li, Kelsey Douthitt, Gregory L Stahl, Joshua M Thurman, Hua Hua Tong.   

Abstract

There is considerable evidence that phase variation among transparent and opaque colony phenotypes of Streptococcus pneumoniae (Spn) plays an important role in the pneumococcal adherence and invasion. The current study was designed to investigate the interactions of the opacity phenotype variants of Spn with specific complement pathway activation in a mouse model of acute otitis media (AOM). Although the opaque colony phenotype was expected to be more resistant to complement mediated killing compared to the transparent Spn variant, we discovered that C3b deposition on the transparent Spn is, in large part, dependent on the alternative pathway activation. There were no significant differences in resistance to complement mediated opsonophagocytosis between the two variants in factor B deficient mice. In addition, an in vitro study demonstrated that significantly more C4b-binding protein (C4BP) (the classical pathway inhibitor) and factor H (FH) (the alternative pathway inhibitor) bound to the transparent strain compared with the opaque one. Our data suggest that the difference in the relative virulence of Spn opacity phenotypes is associated with its ability to evade complement-mediated opsonophagocytosis in a mouse model of pneumococcal AOM.
Copyright © 2012 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22975410      PMCID: PMC3511655          DOI: 10.1016/j.micinf.2012.08.002

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  29 in total

1.  Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies.

Authors:  M Botto; C Dell'Agnola; A E Bygrave; E M Thompson; H T Cook; F Petry; M Loos; P P Pandolfi; M J Walport
Journal:  Nat Genet       Date:  1998-05       Impact factor: 38.330

2.  Nasal colonization with Streptococcus pneumoniae includes subpopulations of surface and invasive pneumococci.

Authors:  David E Briles; Lea Novak; Muneki Hotomi; Frederik W van Ginkel; Janice King
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

3.  Evaluation of the mouse model for acute otitis media.

Authors:  Carol J MacArthur; Steven H Hefeneider; J Beth Kempton; Sarah K Parrish; Sharon L McCoy; Dennis R Trune
Journal:  Hear Res       Date:  2006-08-02       Impact factor: 3.208

4.  Abrogation of the alternative complement pathway by targeted deletion of murine factor B.

Authors:  M Matsumoto; W Fukuda; A Circolo; J Goellner; J Strauss-Schoenberger; X Wang; S Fujita; T Hidvegi; D D Chaplin; H R Colten
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

5.  A targeted disruption of the murine complement factor B gene resulting in loss of expression of three genes in close proximity, factor B, C2, and D17H6S45.

Authors:  P R Taylor; J T Nash; E Theodoridis; A E Bygrave; M J Walport; M Botto
Journal:  J Biol Chem       Date:  1998-01-16       Impact factor: 5.157

6.  Species-specific interaction of Streptococcus pneumoniae with human complement factor H.

Authors:  Ling Lu; Zhuo Ma; T Sakari Jokiranta; Adeline R Whitney; Frank R DeLeo; Jing-Ren Zhang
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

7.  Interaction of pneumococcal phase variation and middle ear pressure/gas composition: an in vitro model of simulated otitis media.

Authors:  Ha-Sheng Li-Korotky; Juliane M Banks; Chia-Yee Lo; Fan-Rui Zeng; Donna B Stolz; J Douglas Swarts; William J Doyle
Journal:  Microb Pathog       Date:  2008-06-03       Impact factor: 3.738

8.  Role of complement in host defense against pneumococcal otitis media.

Authors:  Vishakha Sabharwal; Sanjay Ram; Marisol Figueira; In Ho Park; Stephen I Pelton
Journal:  Infect Immun       Date:  2009-01-12       Impact factor: 3.441

9.  Impaired opsonization with C3b and phagocytosis of Streptococcus pneumoniae in sera from subjects with defects in the classical complement pathway.

Authors:  Jose Yuste; Ashwin Sen; Lennart Truedsson; Göran Jönsson; Liang-Seah Tay; Catherine Hyams; Helen E Baxendale; Fiona Goldblatt; Marina Botto; Jeremy S Brown
Journal:  Infect Immun       Date:  2008-06-09       Impact factor: 3.441

10.  Relationship between cell surface carbohydrates and intrastrain variation on opsonophagocytosis of Streptococcus pneumoniae.

Authors:  J O Kim; S Romero-Steiner; U B Sørensen; J Blom; M Carvalho; S Barnard; G Carlone; J N Weiser
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

View more
  8 in total

1.  Annexin A2 Enhances Complement Activation by Inhibiting Factor H.

Authors:  Brandon Renner; Hua Hua Tong; Jennifer Laskowski; Karen Jonscher; Lindsey Goetz; Rachel Woolaver; Jonathan Hannan; Yong Xing Li; Dennis Hourcade; Matthew C Pickering; V Michael Holers; Joshua M Thurman
Journal:  J Immunol       Date:  2016-01-04       Impact factor: 5.422

Review 2.  Panel 4: Report of the Microbiology Panel.

Authors:  Stephen J Barenkamp; Tasnee Chonmaitree; Anders P Hakansson; Terho Heikkinen; Samantha King; Johanna Nokso-Koivisto; Laura A Novotny; Janak A Patel; Melinda Pettigrew; W Edward Swords
Journal:  Otolaryngol Head Neck Surg       Date:  2017-04       Impact factor: 3.497

3.  Streptococcus pneumoniae PspC Subgroup Prevalence in Invasive Disease and Differences in Contribution to Complement Evasion.

Authors:  Erika van der Maten; Bryan van den Broek; Marien I de Jonge; Kim J W Rensen; Marc J Eleveld; Aldert L Zomer; Amelieke J H Cremers; Gerben Ferwerda; Ronald de Groot; Jeroen D Langereis; Michiel van der Flier
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

4.  Anatomical site-specific contributions of pneumococcal virulence determinants.

Authors:  Anukul T Shenoy; Carlos J Orihuela
Journal:  Pneumonia (Nathan)       Date:  2016-06-03

5.  Increased activity of the complement system in cerebrospinal fluid of the patients with Non-HIV Cryptococcal meningitis.

Authors:  Lei Shen; Jianming Zheng; Yan Wang; Mengqi Zhu; Haoxiang Zhu; Qi Cheng; Qian Li
Journal:  BMC Infect Dis       Date:  2017-01-04       Impact factor: 3.090

Review 6.  Role of Streptococcus pneumoniae Proteins in Evasion of Complement-Mediated Immunity.

Authors:  Greiciely O Andre; Thiago R Converso; Walter R Politano; Lucio F C Ferraz; Marcelo L Ribeiro; Luciana C C Leite; Michelle Darrieux
Journal:  Front Microbiol       Date:  2017-02-20       Impact factor: 5.640

Review 7.  Subversion of host immune responses by otopathogens during otitis media.

Authors:  James M Parrish; Manasi Soni; Rahul Mittal
Journal:  J Leukoc Biol       Date:  2019-05-10       Impact factor: 4.962

8.  Lower level of complement component C3 and C3a in the plasma means poor outcome in the patients with hepatitis B virus related acute-on-chronic liver failure.

Authors:  Qian Li; Qing Lu; Meng-Qi Zhu; Chong Huang; Kang-Kang Yu; Yu-Xian Huang; Xu Zhao; Xing-Guang Luo; Jian-Ming Zheng
Journal:  BMC Gastroenterol       Date:  2020-04-15       Impact factor: 3.067

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.